What You Ought to Know:
– Cognizant (Nasdaq: CTSH) introduced an expanded settlement with Medidata, a Dassault Systèmes model and chief of scientific trial options to the life sciences trade, to offer help for Medidata’s life sciences shoppers and develop the strategic alliance partnership.
– Through the years, the businesses have partnered to ship a complete framework supporting life sciences shoppers, emphasizing buyer success, affected person service desk, implementation, engineering, integrations, and consumer acceptance testing providers utilizing Medidata’s scientific platform and options.
Cognizant and Medidata: Reworking Scientific Analysis By AI-Powered Innovation
Cognizant (Nasdaq: CTSH) engineers trendy companies by serving to shoppers modernize know-how, reimagine processes, and rework experiences to remain forward in a fast-changing world. In a renewed multi-year collaboration, Cognizant and Medidata purpose to boost responsiveness and enhance consumer satisfaction for all times sciences organizations counting on Medidata’s know-how providers for scientific trial growth.
· Devoted Medidata Platform Help: Cognizant gives a specialised workforce of Medidata Platform consultants to help pharmaceutical, biotech, medical machine, and contract analysis organizations, in addition to sufferers utilizing Medidata providers. This help maximizes Medidata’s worth for all times sciences shoppers, enhancing the general consumer expertise and enabling shoppers to concentrate on scientific trial growth and affected person outcomes.
· AI-Pushed Scientific Trial Acceleration: The partnership expands entry to Medidata’s AI-powered applied sciences, together with Medidata Scientific Knowledge Studio, Medidata Well being File Join, and the myMedidata affected person portal. These options streamline analysis and growth by enhancing affected person, web site, and information experiences.
· Operational Excellence and Knowledge Modernization: As a prime International Medidata Strategic Alliance Associate, Cognizant leverages its intensive community of Medidata Licensed Providers Professionals to assist life sciences organizations modernize scientific operations and information administration.
“Our partnership with Cognizant represents a shared dedication to reworking scientific analysis by means of innovation and experience,” stated Janet Butler, EVP, Head of International Gross sales, Medidata. “By combining Medidata’s superior AI-driven applied sciences with Cognizant’s deep trade information and operational excellence, we help life sciences organizations in streamlining their R&D efforts, deriving actionable insights from advanced information, and finally bringing life-changing therapies to sufferers extra effectively.”
